Desq Long
Sign in

Company

Artiva Biotherapeutics, Inc.

ARTV · CIK 0001817241

SEC FORM 4
$0.00

Artiva Biotherapeutics, Inc. (ARTV)

Acquisition (code A) of 110,000 shares at $0 per share.

Reporting Person Aslan Fred · Officer Title Chief Executive Officer · Transaction Code A

Traded Sep 15, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001193125-26-392025 · filed 2026-09-15 · View filing →

SEC FORM 4
$0.00

Artiva Biotherapeutics, Inc. (ARTV)

Acquisition (code A) of 45,000 shares at $0 per share.

Reporting Person Aslan Fred · Officer Title Chief Executive Officer · Transaction Code A

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0001193125-26-391012 · filed 2026-09-14 · View filing →

SEC FORM 4
$0.00

Artiva Biotherapeutics, Inc. (ARTV)

Acquisition (code A) of 30,000 shares at $0 per share.

Reporting Person Banerjee Subhashis · Officer Title Chief Medical Officer · Transaction Code A

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001193125-26-389510 · filed 2026-09-11 · View filing →

SEC FORM 4
$0.00

Artiva Biotherapeutics, Inc. (ARTV)

Acquisition (code A) of 45,000 shares at $0 per share.

Reporting Person Bush Jennifer · Officer Title COO, CLO, Compliance Officer · Transaction Code A

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001193125-26-389511 · filed 2026-09-11 · View filing →

SEC FORM 4
$0.00

Artiva Biotherapeutics, Inc. (ARTV)

Acquisition (code A) of 40,000 shares at $0 per share.

Reporting Person Horan Christopher · Officer Title Chief Tech Operations Officer · Transaction Code A

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001193125-26-389512 · filed 2026-09-11 · View filing →

SEC FORM 4
$0.00

Artiva Biotherapeutics, Inc. (ARTV)

Acquisition (code A) of 45,000 shares at $0 per share.

Reporting Person Miralles Gines Diego · Officer Title President & Head of R&D · Transaction Code A

Traded Sep 9, 2026 · Disclosed Sep 11, 2026

Source: SEC Form 4 · 0001193125-26-389514 · filed 2026-09-11 · View filing →

SEC FORM 4
$255,746.28

Artiva Biotherapeutics, Inc. (ARTV)

Sale of 23,429 shares at $10.9158 per share.

Reporting Person Aslan Fred · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001193125-26-386431 · filed 2026-09-09 · View filing →

SEC FORM 4
$690,391.58

Artiva Biotherapeutics, Inc. (ARTV)

Sale of 61,888 shares at $11.1555 per share.

Reporting Person Aslan Fred · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001193125-26-383618 · filed 2026-09-04 · View filing →

SEC FORM 4
$12,271.16

Artiva Biotherapeutics, Inc. (ARTV)

Sale of 1,100 shares at $11.1556 per share.

Reporting Person Banerjee Subhashis · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001193125-26-383619 · filed 2026-09-04 · View filing →

SEC FORM 4
$93,605.80

Artiva Biotherapeutics, Inc. (ARTV)

Sale of 8,391 shares at $11.1555 per share.

Reporting Person Bush Jennifer · Officer Title COO, CLO, Compliance Officer · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001193125-26-383621 · filed 2026-09-04 · View filing →

SEC FORM 4
$115,637.91

Artiva Biotherapeutics, Inc. (ARTV)

Sale of 10,366 shares at $11.1555 per share.

Reporting Person Horan Christopher · Officer Title Chief Tech Operations Officer · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001193125-26-383625 · filed 2026-09-04 · View filing →

SEC FORM 4
$10,187.52

Artiva Biotherapeutics, Inc. (ARTV)

Acquisition (code M) of 5,306 shares at $1.92 per share.

Reporting Person Banerjee Subhashis · Officer Title Chief Medical Officer · Transaction Code M

Traded Aug 27, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001193125-26-377207 · filed 2026-08-31 · View filing →

SEC FORM 4
$98,735.53

Artiva Biotherapeutics, Inc. (ARTV)

Sale of 8,222 shares at $12.0087 per share.

Reporting Person Banerjee Subhashis · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 27, 2026 · Disclosed Aug 31, 2026

Source: SEC Form 4 · 0001193125-26-377207 · filed 2026-08-31 · View filing →

SEC FORM 4
$823.68

Artiva Biotherapeutics, Inc. (ARTV)

Acquisition (code M) of 429 shares at $1.92 per share.

Reporting Person Banerjee Subhashis · Officer Title Chief Medical Officer · Transaction Code M

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001193125-26-357383 · filed 2026-08-19 · View filing →

SEC FORM 4
$5,148.00

Artiva Biotherapeutics, Inc. (ARTV)

Sale of 429 shares at $12.00 per share.

Reporting Person Banerjee Subhashis · Officer Title Chief Medical Officer · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 19, 2026

Source: SEC Form 4 · 0001193125-26-357383 · filed 2026-08-19 · View filing →